Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-09-01 Sale |
2020-09-03 4:12 pm |
Allogene Therapeutics Inc. | ALLO | Bhavnagri Veer General Counsel |
25,000 | $35.36 | $883,966 | 602,702 (Direct) |
View |
| 2020-08-06 Sale |
2020-08-10 4:34 pm |
Allogene Therapeutics Inc. | ALLO | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G 10% Owner |
37,445 | $37.47 | $1,403,031 | 19,678,861 (Indirect) |
View |
| 2020-08-03 Sale |
2020-08-05 5:09 pm |
Allogene Therapeutics Inc. | ALLO | Bhavnagri Veer General Counsel |
31,553 | $36.89 | $1,164,121 | 627,702 (Direct) |
View |
| 2020-06-26 Sale |
2020-06-30 4:53 pm |
Allogene Therapeutics Inc. | ALLO | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G 10% Owner |
85,151 | $42.53 | $3,621,601 | 19,716,306 (Indirect) |
View |
| 2020-06-23 Sale |
2020-06-25 6:24 pm |
Allogene Therapeutics Inc. | ALLO | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G 10% Owner |
219,853 | $44.04 | $9,682,651 | 19,801,457 (Indirect) |
View |
| 2020-06-18 Sale |
2020-06-22 6:25 pm |
Allogene Therapeutics Inc. | ALLO | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G 10% Owner |
314,792 | $42.5 | $13,379,623 | 20,021,310 (Indirect) |
View |
| 2020-06-15 Sale |
2020-06-17 6:13 pm |
Allogene Therapeutics Inc. | ALLO | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G 10% Owner |
390,984 | $42.18 | $16,491,046 | 20,336,102 (Indirect) |
View |
| 2020-06-03 Sale |
2020-06-05 5:43 pm |
Allogene Therapeutics Inc. | ALLO | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G 10% Owner |
489,220 | $47.4 | $23,188,152 | 20,727,086 (Indirect) |
View |
| 2020-06-04 Purchase |
2020-06-04 4:04 pm |
Allogene Therapeutics Inc. | ALLO | Belldegrun Arie Director |
146,382 | $47 | $6,879,954 | 6,447,492 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-09-01 Exercise |
2020-09-03 4:12 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | Bhavnagri Veer General Counsel |
25,000 | $2.27 | 602,702 (Direct) |
View |
| 2020-09-01 Exercise |
2020-09-03 4:12 pm |
N/A 2028-06-25 |
Allogene Therapeutics Inc. | ALLO | Bhavnagri Veer General Counsel |
25,000 | $0 | 602,702 (Direct) |
View |
| 2020-08-13 Exercise |
2020-08-14 4:04 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | MOORE ALISON Chief Technical Officer |
32,451 | $2.27 | 812,023 (Direct) |
View |
| 2020-08-13 Exercise |
2020-08-14 4:04 pm |
N/A 2028-06-25 |
Allogene Therapeutics Inc. | ALLO | MOORE ALISON Chief Technical Officer |
32,451 | $0 | 812,023 (Direct) |
View |
| 2020-08-06 Other |
2020-08-10 4:34 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G 10% Owner |
962,555 | $0 | 19,678,861 (Indirect) |
View |
| 2020-08-03 Exercise |
2020-08-05 5:09 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | Bhavnagri Veer General Counsel |
25,000 | $2.27 | 627,702 (Direct) |
View |
| 2020-08-03 Exercise |
2020-08-05 5:09 pm |
N/A 2028-06-25 |
Allogene Therapeutics Inc. | ALLO | Bhavnagri Veer General Counsel |
25,000 | $0 | 627,702 (Direct) |
View |
| 2020-06-05 Option Award |
2020-06-09 4:06 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | WITTE OWEN N. Director |
9,969 | $0 | 246,151 (Direct) |
View |
| 2020-06-05 Option Award |
2020-06-09 4:05 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | Humer Franz B Director |
9,969 | $0 | 131,216 (Direct) |
View |
| 2020-06-05 Option Award |
2020-06-09 4:04 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | Kazam Joshua A Director |
9,969 | $0 | 1,033,305 (Direct) |
View |
| 2020-06-05 Option Award |
2020-06-09 4:03 pm |
N/A 2030-06-05 |
Allogene Therapeutics Inc. | ALLO | MESSEMER DEBORAH M. Director |
16,640 | $0 | 16,640 (Direct) |
View |
| 2020-04-24 Other |
2020-04-28 4:33 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | Kazam Joshua A Director |
8,039 | $0 | 1,031,375 (Direct) |
View |
| 2020-04-24 Other |
2020-04-28 4:32 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | Chang David D President and CEO |
18,385 | $0 | 2,892,752 (Indirect) |
View |
| 2020-03-18 Gift |
2020-04-28 4:32 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | Chang David D President and CEO |
428,022 | $0 | 2,892,752 (Indirect) |
View |